Clinical observation of sparfloxacin in the treatment of ureaplasma urealyticum prostatitis
10.3969/j.issn.1005-1678.2016.04.23
- VernacularTitle:司帕沙星治疗解脲尿枝原体性前列腺炎的疗效观察
- Author:
Rong HUANG
;
Xiting TANG
- Publication Type:Journal Article
- Keywords:
sparfloxacin;
ureaplasma urealyticum;
prostatitis;
curative effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(4):80-82
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical effect of sparfloxacin on the treatment of ureaplasma urealyticum prostatitis.Methods 96 cases with ureaplasma urealyticum prostatitis, which admitted in our hospital, were selected as the research object and divided into observation group ( n =48 cases) and control group ( n=48 cases) randomly.The control group was given the ofloxacin for treatment and the observation group was given the sparfloxacin for treatment.The clinical effect of the two groups after treatment was analyzed.Results The total effective rate of the observation group (97.92%) was significantly higher than that of the control group (72.92%) (P<0.05).After treatment, the total incidence of adverse reactions of the observation group(8.33%) compared with that of the control group (10.42%), had no significant difference(P>0.05).Conclusion Patients with ureaplasma urealyticum prostatitis, the treatment effect of sparfloxacin is significant, with lower adverse reactions rate and the security is higher, which is recognized in the medical community, can be worthy of popularization and application in clinic.
